| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.034 | 0.5 |